Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

RCVS Knowledge - Evidence-based Veterinary Medicine

In this Audio Summary, Bonnie looks at whether lokivetmab is more effective than oclacitinib in reducing the Canine Atopic Dermatitis Lesion Index score (or some other recognised scoring system), in dogs with atopic skin disease. Read the full Knowledge Summary here.

Audio Summaries are a free resource that enable vets and vet nurses to more quickly and more easily access and digest relevant and up-to-date evidence! A time-saving way to make better and faster evidence-based decisions.